Inventor
ANDERSON STEPHEN
US82 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
15 patentsUS5262170ANov 16, 1993
Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
GENENTECH INC22 citations96
US5032514AJul 16, 1991
Metabolic pathway engineering to increase production of ascorbic acid intermediates
GENENTECH INC76 citations93
US5108901AApr 28, 1992
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC38 citations92
US5008193AApr 16, 1991
Ascorbic acid intermediates and process enzymes
GENENTECH INC43 citations91
US5770426AJun 23, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC7 citations82
US5616486AApr 1, 1997
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC13 citations82
US5520913AMay 28, 1996
Tissue plasminogen activator having zymogenic properties
GENENTECH INC13 citations82
US5411871AMay 2, 1995
Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC10 citations82
US5405771AApr 11, 1995
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations82
US5520911AMay 28, 1996
Variants of plasminogen activators and processes for their production
GENENTECH INC16 citations81
US5385732AJan 31, 1995
Variants of tissue plasminogen activator, compositions and methods of use for same
GENENTECH INC17 citations81
US5840564ANov 24, 1998
Tussue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC4 citations74
US5714145AFeb 3, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations74
US5346824ASep 13, 1994
DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof
GENENTECH INC7 citations73
US5270198ADec 14, 1993
DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GENENTECH INC9 citations73
UNIV RUTGERS
8 patentsUS5589154ADec 31, 1996
Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
UNIV RUTGERS153 citations99
US6471960B1Oct 29, 2002
Methods for the prevention or treatment of alzheimer's disease
UNIV RUTGERS43 citations96
US5550213AAug 27, 1996
Inhibitors of urokinase plasminogen activator
UNIV RUTGERS55 citations95
US5376544ADec 27, 1994
Enzymes for the production of 2-keto-L-gulonic acid
UNIV RUTGERS52 citations95
US6136548AOct 24, 2000
Methods for identifying useful T-PA mutant derivatives for treatment of vascular hemorrhaging
UNIV RUTGERS27 citations93
US5912161AJun 15, 1999
Enzymes for the production of 2-keto-L-gulonic acid
UNIV RUTGERS18 citations92
US5795761AAug 18, 1998
Mutants of 2,5-diketo-D-gluconic acid (2,5-DKG) reductase A
UNIV RUTGERS42 citations92
US5583025ADec 10, 1996
Enzymes for the production of 2-keto-L-gulonic acid
UNIV RUTGERS26 citations92
PFIZER
6 patentsUS10590087B1Mar 17, 2020
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
PFIZER39 citations97
US11566006B2Jan 31, 2023
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
PFIZER7 citations93
US10941118B2Mar 9, 2021
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
PFIZER13 citations93
US10710966B1Jul 14, 2020
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
PFIZER20 citations93
US11884635B2Jan 30, 2024
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
PFIZER3 citations85
US11845732B2Dec 19, 2023
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
PFIZER3 citations83
MOLECULAR TOOL INC
3 patentsUS6004744ADec 21, 1999
Method for determining nucleotide identity through extension of immobilized primer
MOLECULAR TOOL INC453 citations99
US5888819AMar 30, 1999
Method for determining nucleotide identity through primer extension
MOLECULAR TOOL INC422 citations99
US5837860ANov 17, 1998
Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds
MOLECULAR TOOL INC257 citations97
LAPLACE INTERVENTIONAL INC
3 patentsUS11109965B2Sep 7, 2021
Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels
LAPLACE INTERVENTIONAL INC15 citations93
US11701223B2Jul 18, 2023
Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels
LAPLACE INTERVENTIONAL INC6 citations84
US11337801B2May 24, 2022
Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels
LAPLACE INTERVENTIONAL INC10 citations84
NCR CORP
3 patentsNEUERE LLC
2 patentsOMNIA MEDICAL LLC
2 patentsSANOFI PASTEUR BIOLOGICS LLC
2 patentsLEVER BROTHERS LTD
1 patentZIMMER SPINE INC
1 patentMICROSOFT CORP
1 patentORCHID BIOSCIENCES INC
1 patentBUCKEYE TECHNOLOGIES
1 patentGM GLOBAL TECH OPERATIONS LLC
1 patentShowing the top 50 of 82 patents by PatentIndex Score.